Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial (vol 114, pg 999, 2009)

被引：0
|
作者：
McClung, M.
Miller, P.
Recknor, C.
Messenbrink, P.
Bucci-Rechtweg, C.
Benhamou, C. -L.
机构：
来源：
OBSTETRICS AND GYNECOLOGY | 2010年 / 115卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1308 / 1308
页数：1
相关论文
共 50 条
  • [31] Nitrates Do Not Affect Bone Density or Bone Turnover in Postmenopausal Women: A Randomized Controlled Trial
    Bolland, Mark J.
    House, Meaghan E.
    Horne, Anne M.
    Pinel, Veronica
    Gamble, Greg D.
    Grey, Andrew
    Reid, Ian R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (06) : 1040 - 1047
  • [32] Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women
    Bilek, Laura D.
    Waltman, Nancy L.
    Lappe, Joan M.
    Kupzyk, Kevin A.
    Mack, Lynn R.
    Cullen, Diane M.
    Berg, Kris
    Langel, Meghan
    Meisinger, Melissa
    Portelli-Trinidad, Ashlee
    Lang, Molly
    BMC WOMENS HEALTH, 2016, 16
  • [33] Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women
    Laura D. Bilek
    Nancy L. Waltman
    Joan M. Lappe
    Kevin A. Kupzyk
    Lynn R. Mack
    Diane M. Cullen
    Kris Berg
    Meghan Langel
    Melissa Meisinger
    Ashlee Portelli-Trinidad
    Molly Lang
    BMC Women's Health, 16
  • [34] Risedronate reverses bone loss in postmenopausal women with low bone mass: Results from a multinational, double-blind, placebo-controlled trial
    Fogelman, I
    Ribot, C
    Smith, R
    Ethgen, D
    Sod, E
    Reginster, JY
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05): : 1895 - 1900
  • [35] PREVENTING BONE LOSS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS AND LOW-TRAUMA FOREARM FRACTURES
    Cirstoiu, M.
    Cirstoiu, C.
    Popescu, D.
    Popescu, A.
    Ene, R.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S647 - S648
  • [36] Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial
    Hooper, MJ
    Ebeling, PR
    Roberts, AP
    Graham, JJ
    Nicholson, GC
    D'Emden, M
    Ernst, TF
    Wenderoth, D
    CLIMACTERIC, 2005, 8 (03) : 251 - 262
  • [37] PREVENTING BONE LOSS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS AND LOW-TRAUMA FOREARM FRACTURES
    Cirstoiu, C. F.
    Popescu, D.
    Ene, R.
    Cirstoiu, M.
    Popescu, A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 143 - 144
  • [38] Intravenous zoledronic acid in postmenopausal women with low bone mineral density. Comment
    Shmerling, RH
    Goldring, SR
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (02) : 151 - 152
  • [39] Bone Loading Exercises Versus Risedronate for the Prevention of Osteoporosis in Postmenopausal Women with Low Bone Mass
    Bilek, Laura
    Flores, Laura
    Kupzyk, Kevin
    Mack, Lynn
    Lappe, Joan
    Waltman, Nancy
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 196 - 196
  • [40] EFFECT OF ZOLEDRONIC ACID COMPARED TO RALOXIFENE ON BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Simon, James A.
    Bachmann, Gloria
    Warren, Michelle
    Kemp, Charisse
    Kianifard, Farid
    Goncalves, Joana
    Kriegman, Audrey
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S204 - S205
12345